|
2011 - 2012 Board of Directors
AUGS members are represented by a 12 member Board of Directors who is responsible for setting the overall strategic direction of the society. The Board is comprised of five officers and seven Directors-at-Large. The officers of the society include a President, President-Elect, Vice President, Immediate Past President and a Treasurer. For more information on how you can become involved on the AUGS Board or a committee, please click here. To view the updated AUGS Bylaws, please click here.
Terms expire at the conclusion of the annual scientific meeting for the year indicated.
|
Officers
President
Matthew Barber, MD
Cleveland Clinic Foundation
Cleveland, OH
Corporate Disclosures: N/A
Term Expires: 2012
|
|
President-Elect
Anthony G. Visco, M.D.
Duke University Medical Center
Durham, NC
Corporate Disclosures: Consultant, Intuitive Surgical
Term Expires: 2012
|
|
Vice President
Charles W. Nager, M.D.
University of California, San Diego
La Jolla, CA
Term Expires: 2012
|
|
Treasurer
John B. Gebhart, MD, MS
Mayo Clinic
Rochester, MN
Corporate Disclosures: Medical Consulting,
CP; Consultant, Ethicon; Consultant,
Coloplast; Reasearch, AMS
Term Expires: 2012
|
|
Immediate Past President
Deb Myers, MD
Brown Medical School, Center for Women’s Surgery
Providence, RI
Corporate Disclosures: N/A
Term Expires: 2012
|
Directors-at-Large:
|
Douglass S. Hale, M.D.
Methodist Hospital of Indiana
Indianapolis, IN
Term Expires: 2014
|
|
Kimberly S. Kenton, MD, MS
Loyola University Medical Center
Maywood, IL
Corporate Disclosures: Consultant/Advisory Board,
Intuitive Surgical
Term Expires: 2013
|
|
AUGS Foundation Vice Chair
Catherine A. Matthews, M.D.
University of North Carolina, Chapel Hill
Chapel Hill, NC
Term Expires: 2014
|
|
Karen L. Noblett, M.D.
University of California Irvine Medical Center
Orange, CA
Term Expires: 2014
|
|
Holly E. Richter, PhD, MD
University of Alabama at Birmingham
Birmingham, AL
Corporate Disclosures: Research grants/Advisory board,
Astellas Pharma; Consultant/advisory board,
IDEO; Research grants/speakers bureau,
Pfizer; Consultant/advisory board,
Uromedica; Consultant/advisory board,
Xanodyne Pharmaceutical; Research grants,
Eli Lilly; Research grants, Warner Chilcott
Term Expires: 2013
|
|
Amy Rosenman, MD
Geffen School of Medicine at UCLA
Santa Monica, CA
Corporate Disclosures: N/A
Term Expires: 2012
|
|
Joe Schaffer, MD
University of Texas Southwestern Medical Center
at Dallas, Dallas, TX
Corporate Disclosures: Speakers Bureau, Astellas/GSK
Term Expires: 2012
|
|
AUGS Foundation Chair
Kristene Whitmore, MD
Corporate Disclosures: Research grants,
Pfizer; Research grants, Allergan; Research grants, Coloplast
|
Ex-Officio Member:
Executive Director
Michelle Zinnert
|
